False Claims Act: Biogen to Pay $900 Million: Whistleblower Gets $250 Million

Monitor Mondays

Oct 3 2022 • 31 mins

According to the U.S. Department of Justice, pharmaceutical giant Biogen will pay $900 million to settle a lawsuit that alleged the company gave doctors kickbacks to encourage them prescribe its drugs. The settlement resolves a lawsuit filed and litigated by former Biogen employee Michael Bawduniak against Biogen under the qui tam or whistleblower provisions of the federal False Claims Act. Famed whistleblower Mary Inman will report this story during the next live edition of Monitor Mondays. Inman, reporting from her London office, is expected to provide details on the settlement.

Other segments will include these instantly recognizable broadcast segments:

  • The RAC Report: Healthcare attorney Knicole Emanuel, partner at the law firm of Practus, will report the latest news about auditors.

  • Risky Business: Healthcare attorney David Glaser, shareholder in the law offices of Fredrikson & Bryon, will join the broadcast with his trademark segment.

  • SDoH Report: Tiffany Ferguson, a subject matter expert on the social determinants of health (SDoH), will report on the news that’s happening at the intersection of healthcare regulations and the SDoH.

  • Monday Rounds: Ronald Hirsch, MD, vice president of R1 RCM, will be making his Monday Rounds with another installment of his popular segment.

  • Legislative Update: Matthew Albright, chief legislative affairs analyst for Zelis, who will report on current healthcare legislation.